Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue

World Journal of Pediatrics

Volumn 16, Issue 3, 2020, Pages 219-221

  Shen, Kun Ling ^a,b,c   Yang, Yong Hong ^a,c,d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c China CDC   (China)

^d Beijing Pediatric Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA INTERFERON; ANTIVIRUS AGENT; INTERFERON;

CHILDHOOD DISEASE; CLINICAL FEATURE; CORONAVIRUS DISEASE 2019; DRUG EFFICACY; EDITORIAL; EPIDEMIC; HUMAN; NONHUMAN; PEDIATRIC PATIENT; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRUS PNEUMONIA; ADOLESCENT; AGE; CHILD; CHINA; CORONAVIRUS INFECTION; FEMALE; INCIDENCE; INFANT; LABORATORY TECHNIQUE; MALE; PANDEMIC; PRESCHOOL CHILD; PROCEDURES; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERITY OF ILLNESS INDEX; SEX FACTOR;

ADOLESCENT; AGE FACTORS; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CHINA; CLINICAL LABORATORY TECHNIQUES; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; FEMALE; HUMANS; INCIDENCE; INFANT; INTERFERONS; MALE; PANDEMICS; PNEUMONIA, VIRAL; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 85079501279     PISSN: 17088569     EISSN: 18670687     Source Type: Journal    
DOI: 10.1007/s12519-020-00344-6     Document Type: Editorial

References (14)

1. National Health Commission of People’s Republic of China. https://www.nhc.gov.cn/xcs/yqfkdt/202001/a53e6df293cc4ff0b5a16ddf7b6b2b31.shtml. Accessed 30 Jan 2020.
2. Li ZZ, Shen KL, Wei XM, Wang HL, Lu J, Tian H, et al. Clinical analysis of pediatric SARS cases in Beijing. Chin J Pediatr. 2003;41:574–7 (in Chinese).
3. Yang YH. Concern for severe acute respiratory syndrome. Chin J Pediatr. 2003;41:401–2 (in Chinese).
4. Merigan TC, Reed SE, Hall TS, Tyrrell DA. Middle East respiratory syndrome coronavirus in children. Saudi Med J. 2015;36:484–6. DOI: 10.15537/smj.2015.4.10243
5. Merigan TC, Reed SE, Hall TS, Tyrrell DA. Inhibition of respiratory virus infection by locally applied interferon. Lancet. 1973;17:563–7. DOI: 10.1016/S0140-6736(73)90714-9
6. Chen PL, Zhang TX, Hu YH, Zhou CF, Wang SD. A multicenter randomized controlled clinical study of recombinant human interferon-typeα1b in the treatment of viral pneumonia in children. Lin Chuang Er Ke Za Zhi. 2005;23:244–5 (in Chinese).
7. Shang YX, Huang Y, Liu EM, Chen Q, Cao L, Lu M, et al. A multicenter study on the treatment of acute bronchiolitis by nebulized human recombinant human interferon-alpha 1b. Zhongguo Shi Yong Er Ke Za Zhi. 2014;29:840–4 (in Chinese).
8. Xu YL, Tian QL, Jiang TY, Panf BD, Feng X, Pang L, et al. Effect of nebulized inhalation of recombinant human interferon alpha-1b on early treatment of severe hand, foot and mouth disease. Zhonghua Shi-Yong Er Ke Za Zhi. 2015;30:627–30 (in Chinese).
9. Shen KL, Shang YX, Zhang GC, Xu BP, Fu Z, Cao L, et al. Rational use of interferon alpha in pediatrical clinical practice: experts' consensus statement. Zhonghua Shi Yong Er Ke Za Zhi. 2018;33:1301–8 (in Chinese).
10. Shen KL, Shang YX, Zhang H. A multicenter, randomized, controlled clinical study on the efficacy and safety of recombinant human interferon 2b spray (pseudomonas) in the treatment of acute upper respiratory tract infection in children. Zhongguo Shi Yong Er Ke Za Zhi. 2019;34:1010–6 (in Chinese).
11. Gao H, Zhang LL, Qin C, Duan ZJ, Tu XM, Yu ZA, et al. Experimental study on the prevention and treatment of SARS-CoV infection in rhesus monkeys with recombinant human interferon 2b nasal spray. Chin J Exp Clin Virol. 2005;19:207–11 (in Chinese).
12. Wang HQ, Ma LL, Jiang JD, Pang R, Chen YJ, Li YH, et al. Study on the pharmacodynamics of recombinant human interferon alpha 2b against respiratory viruses. Yao Xue Xue Bao. 2014;49:1547–53 (in Chinese).
13. Yu DX, Chen Q, Zhang LL, Liu Y, Yu ZA, Li ZF, et al. Experimental study of recombinant human interferon 2b aerosol in the prevention of respiratory virus infections such as SARS in human populations. Chin J Exp Clin Virol. 2005;19:216–9 (in Chinese).
14. National Health Commission of People’s Republic of China. Diagnosis and treatment of pneumonia caused by novel coronavirus (trial version 4). 2020. https://www.nhc.gov.cn/xcs/zhengcwj/202001/4294563ed35b43209b31739bd0785e67/files/7a9309111267475a99d4306962c8bf78.pdf. Accessed 28 Jan 2020.